{
    "nctId": "NCT06540872",
    "briefTitle": "Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer",
    "officialTitle": "Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Carcinoma, Intraductal, Noninfiltrating",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Evaluation of feasibility of detection of occult invasive cancer in diagnosed DCIS of [68Ga]Ga-FAPI-46 breast PET/MRI",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed DCIS with extent in mammography, MRI or ultrasound suspected to range \\> 4 cm\n* Planned DCIS resection (breast conserving or mastectomy) as per guideline recommendation\n* Written informed consent\n* For women of child bearing potential: confirmed menstrual period (if applicable) and a negative highly sensitive urine or serum pregnancy test\n* Women of childbearing potential (WOCBP) and male patients with partners of childbearing/reproductive potential must agree to use highly effective contraception (Pearl index \\< 1) when sexually active. This applies for the time period between signing of the informed consent form up to the final trial visit.\n\nExclusion Criteria:\n\n* Contraindications for MRI (specific metallic implants, severe claustrophobia, history of anaphylaxis following MRI contrast agent application)\n* GFR \\< 30 mL/(min\u22191.73 m\u00b2)\n* Current pregnancy or within last 8 weeks before begin of study participation\n* Current nursing or within last 8 weeks before begin of study participation\n* Inability to understand the nature, risks, and benefits of the study\n* History of diagnosis of ipsilateral invasive breast cancer\n* Concurrent diagnosis of contralateral invasive cancer, if not curatively treated by surgery \\> 1 year ago\n* Known hypersensitivity to the active substance or to any of the excipients of the Investigational Medicinal Product",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}